Correlation Between GM and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both GM and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on GM and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Cadrenal Therapeutics,.
Diversification Opportunities for GM and Cadrenal Therapeutics,
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GM and Cadrenal is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of GM i.e., GM and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between GM and Cadrenal Therapeutics,
Allowing for the 90-day total investment horizon General Motors is expected to generate 0.31 times more return on investment than Cadrenal Therapeutics,. However, General Motors is 3.21 times less risky than Cadrenal Therapeutics,. It trades about 0.26 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about 0.03 per unit of risk. If you would invest 5,273 in General Motors on August 27, 2024 and sell it today you would earn a total of 580.00 from holding General Motors or generate 11.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
General Motors vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| General Motors |
| Cadrenal Therapeutics, |
GM and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GM and Cadrenal Therapeutics,
The main advantage of trading using opposite GM and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.The idea behind General Motors and Cadrenal Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. HCW Biologics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges |